DRKS00040872进行中（未招募）不适用
Does Augmented Reality Improve Disease Understanding and Outcomes in Psoriatic Arthritis? - ARISE-PSA
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- 干预性
- 分配方式
- 随机
- 干预模型
- 平行分组
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 —（—）
- 性别
- All
入选标准
- Confirmed diagnosis of psoriatic arthritis according to the CASPAR classification criteria
- Active disease (DAPSA >4)
- Current treatment with self-administered medication (e.g. oral or subcutaneous) or planned initiation or switch to such treatment based on clinical indication
- At least one and no more than five previous DMARD therapies
- Self-rated disease-related knowledge of moderately informed or worse
- Ability to complete study questionnaires independently
- Sufficient German language skills
- Written informed consent
排除标准
- Current or planned intravenous antirheumatic therapy
- Other inflammatory rheumatic systemic diseases likely to affect study outcomes
- Severe cognitive impairment or relevant psychiatric disorders
- Neurological disorders or contraindications to Augmented Reality applications (e.g. photosensitive epilepsy)
- Acute severe comorbidities
- Participation in another interventional clinical trial
- Unwillingness or inability to comply with the study protocol
研究组 & 干预措施
Group 1: Intervention group (Augmented Reality-assisted patient education): Following screening, written informed consent and baseline assessments, participants are randomized in a 1:1 ratio. Participants allocated to this study arm receive a single structured 20-minute patient education session on psoriatic arthritis using an Augmented Reality application. The education is delivered by trained medical staff according to a standardized educational protocol and covers disease characteristics, pathophysiology, structural changes, and the principles and goals of medical treatment. Routine medical care remains unchanged throughout the study. Follow-up assessments are performed 1 hour and 4, 12, and 24 weeks after the intervention.
干预措施: Group 1: Intervention group (Augmented Reality-assisted patient education): Following screening, written informed consent and baseline assessments, participants are randomized in a 1:1 ratio. Participants allocated to this study arm receive a single structured 20-minute patient education session on psoriatic arthritis using an Augmented Reality application. The education is delivered by trained medical staff according to a standardized educational protocol and covers disease characteristics, pathophysiology, structural changes, and the principles and goals of medical treatment. Routine medical care remains unchanged throughout the study. Follow-up assessments are performed 1 hour and 4, 12, and 24 weeks after the intervention.
研究者
标识符
- 注册编号
- DRKS00040872
- 其他研究编号
- AZ38/26
日期
- 首次发布
- (2个月前)
- 最近更新
- (上个月)
监管与共享
- 是否有结果
- 否